Mind Medicine (MindMed) (MNMD) News Today → Dems have chosen Biden replacement? (From Paradigm Press) (Ad) Free MNMD Stock Alerts $8.80 -0.01 (-0.11%) (As of 05/31/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 31 at 12:45 PM | marketbeat.comMind Medicine (MindMed) (NASDAQ:MNMD) Trading Up 5.7%Mind Medicine (MindMed) (NASDAQ:MNMD) Trading 5.7% HigherMay 31 at 6:52 AM | americanbankingnews.comMind Medicine (MindMed) (NASDAQ:MNMD) Shares Gap Up to $8.35May 30 at 6:30 AM | americanbankingnews.comMind Medicine (MindMed) (NASDAQ:MNMD) Upgraded to "Strong-Buy" by Baird R WMay 30 at 5:47 AM | marketbeat.comMind Medicine (MindMed) (NASDAQ:MNMD) Upgraded to Strong-Buy by Baird R WBaird R W raised shares of Mind Medicine (MindMed) to a "strong-buy" rating in a report on Wednesday.May 30 at 1:21 AM | marketbeat.comMind Medicine (MindMed) Inc. (NASDAQ:MNMD) Receives Consensus Recommendation of "Buy" from AnalystsShares of Mind Medicine (MindMed) Inc. (NASDAQ:MNMD - Get Free Report) have earned an average rating of "Buy" from the eight ratings firms that are currently covering the stock, MarketBeat Ratings reports. Eight equities research analysts have rated the stock with a buy recommendation. The averageMay 29 at 1:14 PM | msn.comBaird Initiates Coverage of Mind Medicine (MNMD) with Outperform RecommendationMay 29 at 2:56 AM | americanbankingnews.comMind Medicine (MindMed) (NASDAQ:MNMD) Coverage Initiated by Analysts at Robert W. BairdMay 28, 2024 | marketbeat.comMind Medicine (MindMed) (NASDAQ:MNMD) Now Covered by Analysts at Robert W. BairdRobert W. Baird began coverage on Mind Medicine (MindMed) in a research note on Tuesday. They issued an "outperform" rating and a $27.00 target price on the stock.May 28, 2024 | businesswire.comMindMed to Participate in June ConferencesMay 26, 2024 | americanbankingnews.comMind Medicine (MindMed) (NASDAQ:MNMD) Earns "Buy" Rating from HC WainwrightMay 24, 2024 | marketbeat.comMind Medicine (MindMed) (NASDAQ:MNMD) Rating Reiterated by HC WainwrightHC Wainwright reaffirmed a "buy" rating and issued a $35.00 price objective on shares of Mind Medicine (MindMed) in a research note on Friday.May 23, 2024 | investorplace.comThe Time Traveler's Portfolio: 3 Stocks to Buy Now for Massive Returns by 2034May 23, 2024 | seekingalpha.comPsychedelics Closer To Commercialization; Compass Far And Away The LeaderMay 21, 2024 | marketbeat.comMind Medicine (MindMed) (NASDAQ:MNMD) Trading 3% Higher Mind Medicine (MindMed) (NASDAQ:MNMD) Trading 3% HigherMay 15, 2024 | marketbeat.comMind Medicine (MindMed) (NASDAQ:MNMD) Shares Up 5.5%Mind Medicine (MindMed) (NASDAQ:MNMD) Stock Price Up 5.5%May 13, 2024 | marketbeat.comMind Medicine (MindMed) (NASDAQ:MNMD) Stock Price Down 2.9% Following Analyst DowngradeMind Medicine (MindMed) (NASDAQ:MNMD) Stock Price Down 2.9% on Analyst DowngradeMay 13, 2024 | marketbeat.comMind Medicine (MindMed) (NASDAQ:MNMD) Stock Rating Reaffirmed by OppenheimerOppenheimer restated an "outperform" rating and issued a $20.00 target price (down previously from $29.00) on shares of Mind Medicine (MindMed) in a research report on Monday.May 10, 2024 | marketbeat.comMind Medicine (MindMed) (NASDAQ:MNMD) PT Lowered to $35.00HC Wainwright cut their target price on Mind Medicine (MindMed) from $75.00 to $35.00 and set a "buy" rating on the stock in a research report on Friday.May 10, 2024 | investorplace.comTop Russell 2000 Picks: 3 Small-Cap Stocks to Scoop Up This MayMay 9, 2024 | businesswire.comMindMed to Participate at May Investor ConferencesMay 9, 2024 | finance.yahoo.comNew Studies Presented at the International Society for Health Economics and Outcomes Research Meeting (ISPOR 24) Show Growing Burden and Impact of Generalized Anxiety Disorder (GAD) in the USMay 9, 2024 | investorplace.comBiotech Breakthroughs: 3 Stocks on the Verge of Revolutionizing MedicineMay 8, 2024 | finance.yahoo.comMindMed Reports First Quarter 2024 Financial Results and Business UpdatesMay 6, 2024 | marketbeat.comMind Medicine (MindMed) (NASDAQ:MNMD) Shares Down 5.4% Mind Medicine (MindMed) (NASDAQ:MNMD) Stock Price Down 5.4%May 4, 2024 | businesswire.comMindMed Presents Phase 2b Study of MM120 for Generalized Anxiety Disorder (GAD) at American Psychiatric Association (APA) Annual Meeting in New YorkMay 3, 2024 | marketbeat.comMind Medicine (MindMed) (MNMD) Scheduled to Post Earnings on WednesdayMind Medicine (MindMed) (NASDAQ:MNMD) will be releasing earnings after the market closes on Wednesday, May 8, Zacks reports.May 2, 2024 | businesswire.comMindMed to Host Conference Call and Webcast to Discuss First Quarter 2024 Financial Results and Provide Business UpdateApril 29, 2024 | marketbeat.comMind Medicine (MindMed) (NASDAQ:MNMD) Trading Up 5.9%Mind Medicine (MindMed) (NASDAQ:MNMD) Shares Up 5.9%April 26, 2024 | seekingalpha.comMindMed: Breakthrough Status From The FDA For LSD TherapyApril 25, 2024 | investorplace.comThe Top 3 Small-Cap Stocks to Buy in April 2024April 25, 2024 | businesswire.comMindMed to Present at Upcoming May Medical ConferencesApril 25, 2024 | fool.comThis Small-Cap Stock Is Up 140% This Year and Here's Why It Can Go Even HigherApril 23, 2024 | marketbeat.comMind Medicine (MindMed) (NASDAQ:MNMD) Stock Price Up 6.8%Mind Medicine (MindMed) (NASDAQ:MNMD) Shares Up 6.8%April 22, 2024 | marketbeat.comMind Medicine (MindMed) (NASDAQ:MNMD) Trading Down 3.5%Mind Medicine (MindMed) (NASDAQ:MNMD) Trading Down 3.5%April 19, 2024 | msn.comJim Cramer Slams Political Blocking Of 'LSD-Derived Antidepressants,' Citing Strong Test Data 'Showing They Worked'April 18, 2024 | marketbeat.comMind Medicine (MindMed) (NASDAQ:MNMD) Stock Price Down 2.9%Mind Medicine (MindMed) (NASDAQ:MNMD) Stock Price Down 2.9%April 17, 2024 | marketbeat.comLeerink Partnrs Weighs in on Mind Medicine (MindMed) Inc.'s Q1 2024 Earnings (NASDAQ:MNMD)Mind Medicine (MindMed) Inc. (NASDAQ:MNMD - Free Report) - Equities researchers at Leerink Partnrs issued their Q1 2024 earnings estimates for shares of Mind Medicine (MindMed) in a report issued on Monday, April 15th. Leerink Partnrs analyst R. Li forecasts that the company will earn ($1.18) perApril 17, 2024 | marketbeat.comLeerink Partnrs Reaffirms "Outperform" Rating for Mind Medicine (MindMed) (NASDAQ:MNMD)Leerink Partnrs reaffirmed an "outperform" rating on shares of Mind Medicine (MindMed) in a research note on Monday.April 17, 2024 | marketbeat.comMind Medicine (MindMed) (NASDAQ:MNMD) Stock Price Down 3.1%Mind Medicine (MindMed) (NASDAQ:MNMD) Stock Price Down 3.1%April 16, 2024 | msn.comLeerink Partners Initiates Coverage of Mind Medicine (MNMD) with Outperform RecommendationApril 15, 2024 | marketbeat.comMind Medicine (MindMed) Inc. (NASDAQ:MNMD) Short Interest Up 23.2% in MarchMind Medicine (MindMed) Inc. (NASDAQ:MNMD - Get Free Report) was the target of a large growth in short interest during the month of March. As of March 31st, there was short interest totalling 7,230,000 shares, a growth of 23.2% from the March 15th total of 5,870,000 shares. Based on an average trading volume of 2,080,000 shares, the days-to-cover ratio is presently 3.5 days. Currently, 26.8% of the shares of the company are short sold.April 15, 2024 | marketbeat.comSVB Leerink Initiates Coverage on Mind Medicine (MindMed) (NASDAQ:MNMD)SVB Leerink began coverage on shares of Mind Medicine (MindMed) in a research note on Monday. They issued an "outperform" rating and a $20.00 target price for the company.April 11, 2024 | marketbeat.comMind Medicine (MindMed) (NASDAQ:MNMD) Stock Price Down 6.5%Mind Medicine (MindMed) (NASDAQ:MNMD) Shares Down 6.5%April 10, 2024 | marketbeat.comMind Medicine (MindMed) (NASDAQ:MNMD) Stock Price Up 7.3%Mind Medicine (MindMed) (NASDAQ:MNMD) Trading 7.3% HigherApril 10, 2024 | marketbeat.comMind Medicine (MindMed) Inc. (NASDAQ:MNMD) Given Average Recommendation of "Buy" by AnalystsMind Medicine (MindMed) Inc. (NASDAQ:MNMD - Get Free Report) has been given an average recommendation of "Buy" by the six research firms that are covering the stock, Marketbeat.com reports. Six equities research analysts have rated the stock with a buy recommendation. The average twelve-month pricApril 8, 2024 | marketbeat.comMind Medicine (MindMed) (NASDAQ:MNMD) Trading 3.2% Higher Mind Medicine (MindMed) (NASDAQ:MNMD) Trading 3.2% HigherApril 5, 2024 | marketbeat.comMind Medicine (MindMed) (NASDAQ:MNMD) Trading 1.5% Higher Mind Medicine (MindMed) (NASDAQ:MNMD) Stock Price Up 1.5%April 4, 2024 | seekingalpha.comMind Medicine: GAD Program Success Continues With BTD And Positive Treatment DataApril 4, 2024 | marketbeat.comMind Medicine (MindMed) (NASDAQ:MNMD) Shares Gap Up to $11.75Mind Medicine (MindMed) (NASDAQ:MNMD) Shares Gap Up to $11.75April 3, 2024 | marketbeat.comMind Medicine (MindMed) (NASDAQ:MNMD) Stock Price Up 20.2%Mind Medicine (MindMed) (NASDAQ:MNMD) Stock Price Up 20.2% Get Mind Medicine (MindMed) News Delivered to You Automatically Sign up to receive the latest news and ratings for MNMD and its competitors with MarketBeat's FREE daily newsletter. Email Address Do This Before July 30 2024 To Claim Trump’s Gift (Ad)In January 2021, Donald Trump silently rolled out a special gift to the American public… One that top house republicans called “The Key To America’s Economic Future”. You just have to make this simple move before July 30, 2024. MNMD Media Mentions By Week MNMD Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. MNMD News Sentiment▼0.460.78▲Average Medical News Sentiment MNMD News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. MNMD Articles This Week▼132▲MNMD Articles Average Week Get Mind Medicine (MindMed) News Delivered to You Automatically Sign up to receive the latest news and ratings for MNMD and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: TLRY News CRON News USNA News CGC News BTMD News ACB News CDXC News MDWD News FTLF News NAII News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:MNMD) was last updated on 6/1/2024 by MarketBeat.com Staff From Our PartnersDems have chosen Biden replacement?Paradigm PressTrump’s Gift Could Unleash $51 Billion in New WealthWealthpin ProShocking: One AI startup's revenue could surge 4,735%Manward PressMust-See: Elon’s New Invention is Absolutely InsaneInvestorPlaceNvidia has Apple and Microsoft within striking rangeWeiss RatingsDon’t buy a single NVIDIA share before you see this...Behind the MarketsExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersHe Is Giving Away BitcoinCrypto Swap Profits Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Mind Medicine (MindMed) Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
